Search NLS News

The latest issue of our magazine Nordic Life Science is out, don’t forget to sign up for a subscription! This issue includes a special report on obesity, including an exclusive interview with professor Jens Juul Holst, discoverer of the now world-famous GLP-1, other Nordic obesity solutions beyond GLP-1, patient perspectives, investor perspectives, a market overview, and […]

Tino Ebbers, professor in physiological measurements, receives the prize for his outstanding research at the Faculty of Medicine and Health Sciences at Linköping University. Tino Ebbers is awarded the Uncle Adam Prize for ‘conducting ground-breaking and world-leading research on how to quantify and visualize physiological events in the cardiovascular system.’ He will receive a monetary […]

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells’ powerhouses, the mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block mitochondrial function can reverse diet-induced obesity, fatty liver and diabetes in mice. Professor Nils-Göran Larsson’s research group at Karolinska […]

The 20th Anniversary edition of the Anglonordic Life Science Conference took place on 17-18 April in London at the majestic County Hall near Waterloo Bridge.

Robert Edfors is appointed as new Chief Scientific Officer and Senior Vice President Clinical Development. Robert Edfors, MD, PhD will assume the new role on September 1, 2024. Up until then, Thomas Olin will remain as CSO. Thomas Olin, PhD, one of Kancera’s co-founders, possesses extensive expertise concerning the fractalkine program and will continue to […]

Xbrane Biopharma and STADA have entered into an exclusive licensing agreement with US biosimilars specialist Valorum Biologics for their ranibizumab biosimilar candidate. Valorum will pay a license fee of up to USD 45 million, plus royalties on net product sales. This fee, plus royalties paid by Valorum on net sales of the product, will be […]

The double-digit million DKK investment is to set up a new storage and CTS production facility for the pharmaceutical and biotech industries. The expansion site is situated in the Greater Copenhagen area in Medicon Valley. “Through this strategic investment, we are fortifying KLIFO’s foothold in the Nordics while laying a robust foundation for the future,” […]

The European Commission (EC) has approved an indication extension for Aspaveli (pegcetacoplan) for treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Aspaveli is already approved in Europe for the treatment of adults with PNH who are anaemic after treatment with a C5 inhibitor for at least three months. Aspaveli is […]

The company has announced the appointment of Eva Pisa to its Board of Directors. “I am pleased that Dr Eva Pisa has decided to join the board of Elypta. With her background and experience she will help the company to deliver a unique diagnostic technology to patients and society,“ says Elypta Chairman of the Board, […]

IRLAB Therapeutics has  announced a collaboration agreement with the McQuade Center for Strategic Research and Development (MSRD), a member of the global Otsuka family of pharmaceutical companies. IRLAB and MSRD will exclusively collaborate in the development of IRLAB’s novel drug candidate IRL757 for the potential treatment of apathy in Parkinson’s and other neurological conditions through […]